- Home
- DSGN vs TCX Comparison
DSGN vs TCX Comparison
Compare DSGN & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- TCX
- Stock Information
- Founded
- DSGN 2017
- TCX 1992
- Country
- DSGN United States
- TCX Canada
- Employees
- DSGN N/A
- TCX N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- TCX EDP Services
- Sector
- DSGN Health Care
- TCX Technology
- Exchange
- DSGN Nasdaq
- TCX Nasdaq
- Market Cap
- DSGN 208.9M
- TCX 220.5M
- IPO Year
- DSGN 2021
- TCX 1996
- Fundamental
- Price
- DSGN $3.67
- TCX $19.73
- Analyst Decision
- DSGN Hold
- TCX
- Analyst Count
- DSGN 1
- TCX 0
- Target Price
- DSGN $4.00
- TCX N/A
- AVG Volume (30 Days)
- DSGN 89.5K
- TCX 32.9K
- Earning Date
- DSGN 08-04-2025
- TCX 08-07-2025
- Dividend Yield
- DSGN N/A
- TCX N/A
- EPS Growth
- DSGN N/A
- TCX N/A
- EPS
- DSGN N/A
- TCX N/A
- Revenue
- DSGN N/A
- TCX $369,427,000.00
- Revenue This Year
- DSGN N/A
- TCX N/A
- Revenue Next Year
- DSGN N/A
- TCX N/A
- P/E Ratio
- DSGN N/A
- TCX N/A
- Revenue Growth
- DSGN N/A
- TCX 6.66
- 52 Week Low
- DSGN $2.60
- TCX $13.27
- 52 Week High
- DSGN $7.77
- TCX $26.48
- Technical
- Relative Strength Index (RSI)
- DSGN 48.40
- TCX 51.22
- Support Level
- DSGN $3.65
- TCX $19.53
- Resistance Level
- DSGN $4.21
- TCX $20.30
- Average True Range (ATR)
- DSGN 0.23
- TCX 0.65
- MACD
- DSGN -0.00
- TCX -0.14
- Stochastic Oscillator
- DSGN 23.81
- TCX 6.67
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.